Skip to content

← All developments

Tennessee Attorney General · September 29, 2026 · Primary source

Tennessee Attorney General Urges Consumers to Check Eligibility for Generic Drug Settlement Funds

Score 50PRIMARYregulatoryState AGTNCT

Summary

Tennessee Attorney General Jonathan Skrmetti announced that a federal court in the District of Connecticut granted preliminary approval of a multistate distribution plan for approximately $96.5 million in settlements with generic drug manufacturers including Glenmark, Lannett, Bausch, Apotex, Heritage, and Emcure. The settlements resolve allegations that these companies conspired with competitors to inflate prices on certain generic prescription drugs between May 2009 and December 2019. A 48-state and territory coalition negotiated the settlements, and consumers who purchased covered generic drugs during that period may be eligible for compensation through a claims process.

What this may mean

The $96.5 million settlement fund covers consumers and other purchasers harmed by alleged antitrust violations in generic drug pricing, not provider billing or regulatory compliance directly. The preliminary approval of the distribution plan triggers a claims process through AGGenericDrugs.com, with claim forms to be made available when the process opens. Health plans, PBMs, and employers that purchased covered generic drugs during the class period may have standing to file claims as indirect purchasers.

Informational only. Not legal, medical, financial, or other professional advice. Always consult a qualified professional familiar with your specific facts before relying on any item.

Related items